- 期刊
The Prescribing Patterns of Antithrombotic Agents for Prevention of Recurrent Ischemic Stroke
並列摘要
Objectives: Antithrombotic agents are effective in the secondary prevention of ischemic strokes. In the present study, we sought to determine the antithrombotic prescribing patterns of neurologists in patients with first-ever ischemic stroke and also to identify the factors influencing the choice of a specific agent and what changes are made when a recurrent stroke occurs in these patients. Methods: We retrospectively reviewed the medical records of neurology patients who were diagnosed with first-ever ischemic stroke and were antithrombotic naïve from January 1, 2000 to December 31, 2000. Patients' antithrombotic agents at discharge and during the follow-up period were reviewed to identify factors affecting the choice of antithrombotic agents. Results: A total of 376 patients experienced non-fatal first-ever ischemic stroke. Of these, 351 were prescribed antithrombotic agents at discharge, while the remaining 25 were not on antithrombotic treatment. Low-dose aspirin was the most commonly prescribed agent (65%). The most important determinant for the choice of other antiplatelet agents was aspirin intolerance. Not surprisingly, only 36% of the patients with atrial fibrillation were treated with oral anticoagulants at the time of hospital discharge. Conclusion: Aspirin remains the most commonly used antithrombotic agent for the prevention of recurrent stroke among antithrombotic naïve patients with a first-ever ischemic stroke in our institution. Our results demonstrate that current recommendations find their way into clinical practice, but to a limited extent. We aim that all patients discharged from our hospital after strokes must receive appropriate antithrombotic drugs for prevention of recurrent strokes provided if there are no contraindications to therapy.
被引用紀錄
延伸閱讀
- 蕭世美、黃明珠、林靜薇、許立奇（2014）。Related Factors of Severity Change in Ischemic Stroke Patients after Using Thrombolytic Agents。榮總護理，31(2)，176-185。https://doi.org/10.6142/VGHN.31.2.176
- Font, M. À., Krupinski, J., & Arboix, A. (2011). Antithrombotic Medication for Cardioembolic Stroke Prevention. Stroke Research and Treatment, 2011(), 278-300. https://doi.org/10.4061/2011/607852
- Lin, C. C., Lee, K. W., Chang, C. G., Yen, C. H., Hsu, Y. D., Lin, J. C., Chen, G. J., Chin, S. C., Chen, C. Y., & Peng, G. S. (2003). Local Intra-arterial Thrombolytic Therapy for Patients with Acute Ischemic Stroke. Acta Neurologica Taiwanica, 12(1), 7-14. https://doi.org/10.29819/ANT.200303.0002
- 塗慧卿、邱文靜、高翡勵、連金延（2012）。Decreasing the Number of Inefficient Surgical Admissions of Patients Receiving Antithrombotic Agents。醫務管理期刊，13(2)，120-135。https://doi.org/10.6174/JHM2012.13(2).120
- 連立明、陳俊榮、陳威宏、葉建宏、汪漢澄、許維志、徐榮隆、吳令治、謝欣如、邱浩彰（2000）。Preliminary Experience of Treating Acute Ischemic Stroke with Intravenous Tissue Plasminogen Activator。台灣醫學，4(4)，379-387。https://doi.org/10.6320/FJM.2000.4(4).02